The key to reversing cellular aging may lie in a protein responsible for toggling cells between a "young" and an "old" state.

Ridgefield, Conn., U.S., and Ingelheim, Germany Zongertinib would be the first orally administered, targeted therapy for previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell ...

The secret to reversing cellular aging may lie hidden in a single protein that can influence a cell's age from young to old.

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

This study is the first to demonstrate that certain tRNA introns influence gene expression. Scientists have discovered that ...

There are a multitude of products for sale that promise the appearance of eternal youth by erasing wrinkles or firming up jaw ...

Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

The treatment landscape for HER2-positive NSCLC is rapidly evolving as research continues to reveal the genetic drivers of these tumors. Emerging therapies like Pyrotinib (Jiangsu HengRui Medicine), ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

Autophagy is the process by which cells digest and renew their internal structures, recycling damaged or malfunctioning ...

A new study unravels the relationship between mitofusins (mitochondrial proteins) and autophagy. Using gene editing with CRISPR-Cas9, the team has been able to study these proteins without altering ...

Furin is identified as the key enzyme responsible for cleaving the apelin precursor. Inhibiting this cleavage could serve as ...